Volume 14, Number 9—September 2008
Dispatch
Host Range and Genetic Diversity of Arenaviruses in Rodents, United Kingdom
Kim R. Blasdell, Stuart D. Becker, Jane Hurst, Mike Begon, and Malcolm Bennett
Table 2
Percentage nucleotide identities between the study sample sequences (all and from the captive colony only) and previously isolated LCMV and Lassa virus sequences*
| Sequence | All study sequences, % | Captive colony sequences only, % |
|---|---|---|
| All study sequences | 93.6–100 | NS |
| Captive colony sequences only | NS | 97.4–100 |
| LCMV CIPV76001 Pasteur (AF095783; France) | 78.7–80.5 | 78.7–80.5 |
| LCMV CIP97001 (AF079517; France) | 79.4– 83.1 | 80.9–83.1 |
| LCMV Marseille (DQ286931; France) | 82.8– 83.9 | 82.8–83.5 |
| LCMV CH5871 (AF325215; Germany) | 81.6–83.1 | 81.6–83.1 |
| LCMV CH5692 (AF325214; Germany) | 81.3–82.8 | 81.3–82.8 |
| LCMV MX (EU195888; Slovakia) | 78.7–80.5 | 78.7–80.5 |
| LCMV Armstrong (M20869; USA) | 82.8– 85.8 | 83.9–85.8 |
| LCMV WE (M22138) | 82.0–84.3 | 82.0–84.3 |
| Lassa LP (AF181853) | 58.1–59.9 | 58.8–59.9 |
*LCMV, lymphocytic choriomeningitis virus; NS, not shown.
Page created: July 13, 2010
Page updated: July 13, 2010
Page reviewed: July 13, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.